| First Author | Lee D | Year | 2020 |
| Journal | Arch Pharm Res | Volume | 43 |
| Issue | 4 | Pages | 449-461 |
| PubMed ID | 32236798 | Mgi Jnum | J:339024 |
| Mgi Id | MGI:7519244 | Doi | 10.1007/s12272-020-01231-4 |
| Citation | Lee D, et al. (2020) Dietary schizophyllan reduces mitochondrial damage by activating SIRT3 in mice. Arch Pharm Res 43(4):449-461 |
| abstractText | Schizophyllan (SPG), produced by Schizophyllum commune, is an exopolysaccharide with multiple academic and commercial uses, including in the food industry and for various medical functions. We previously demonstrated that SPG conjugated with c-Src peptide exerted a significant therapeutic effect on mouse models of the acute inflammatory diseases polymicrobial sepsis and ulcerative colitis. Here we extended these results by investigating whether SPG exerted a protective effect against mitochondrial damage in the liver via sirtuin 3 (SIRT3) induction, focusing on the deacetylation of succinate dehydrogenase A (SDHA) and superoxide dismutase 2 (SOD2). Liver damage models induced by alcohol or conjugated linoleic acid (CLA, which simulates lipodystrophy) in SIRT3(-/-), SOD2(-/-), and SDHA(-/-) mice were used. Results showed that dietary supplementation with SPG induced SIRT3 activation; this was involved in mitochondrial metabolic resuscitation that countered the adverse effects of alcoholic liver disease and CLA-induced damage. The mitochondrial SIRT3 mediated the deacetylation and activation of SOD2 in the liver and SDHA in adipose tissues, suggesting that SPG supplementation reduced ethanol-induced liver damage and CLA-induced adverse dietary effects via SIRT3-SOD2 and SIRT3-SDHA signaling, respectively. Together, these results suggest that dietary SPG has a previously unrecognized role in SIRT3-mediated mitochondrial metabolic resuscitation during mitochondria-related diseases. |
